化合物INCB057643 T5417
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mL | 1820889-23-3 | ¥1,430.00 | 询底价 |
50 mg | 1820889-23-3 | ¥5,460.00 | 询底价 |
1 mg | 1820889-23-3 | ¥622.00 | 询底价 |
10 mg | 1820889-23-3 | ¥2,290.00 | 询底价 |
2 mg | 1820889-23-3 | ¥913.00 | 询底价 |
500 mg | 1820889-23-3 | ¥14,900.00 | 询底价 |
100 mg | 1820889-23-3 | ¥7,450.00 | 询底价 |
25 mg | 1820889-23-3 | ¥3,830.00 | 询底价 |
5 mg | 1820889-23-3 | ¥1,530.00 | 询底价 |
Product Introduction
Bioactivity
英文名: INCB-057643
描述: INCB-057643 是一种有效的、选择性的和口服生物可利用的 BET 抑制剂。
体外活性: INCB057643 inhibited binding of BRD2/BRD3/BRD4 to an acetylated histone H4 peptide in the low nM range and was selective against other bromodomain-containing proteins. INCB057643 inhibited proliferation of human AML, DLBCL, and multiple myeloma cell lines, with a corresponding decrease in MYC protein levels. Cell cycle analyses indicated that G1 arrest and a concentration-dependent increase in apoptosis were seen within 48 hours of treatment with INCB057643. BRD proteins also regulate the expression of many pro-inflammatory genes. Production of several cytokines, including IL-6, IL-10 and MIP-1α, was repressed by INCB057643 in human and mouse whole blood stimulated ex vivo with LPS [1].
体内活性: Oral administration of INCB057643 resulted in significant anti-tumor efficacy in xenograft models of AML, myeloma, and DLBCL. Additionally, combining INCB057643 with the standard of care agents used for the treatment of DLBCL including rituximab and bendamustine resulted in enhanced anti-tumor efficacy relative to that achieved with single-agent therapies at doses that were well tolerated [1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 60 mg/mL (144.42 mM)
关键字: Apoptosis | Epigenetic Reader Domain | inhibit | Inhibitor | INCB057643 | INCB-057643 | INCB 057643
相关产品: Nelarabine | Otenaproxesul | Bendamustine hydrochloride | Rotenone | Luteolin | TAT-NEP1-40 TFA | Tetrahydropalmatine | Triciribine phosphate | Diallyl Trisulfide | Tandutinib
相关库: Drug Repurposing Compound Library | Anti-Cancer Drug Library | Clinical Compound Library | Bioactive Compounds Library Max | Anti-Cancer Clinical Compound Library | Inhibitor Library | Anti-Cancer Active Compound Library | PPI Inhibitor Library | Apoptosis Compound Library | Bioactive Compound Library
化合物INCB057643 T5417信息由TargetMol中国为您提供,如您想了解更多关于化合物INCB057643 T5417报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途